Home » Topics » Regulatory » Patents

Patents
RSS

Texas Biotechnology prepares new endothelin modulators

Jan. 15, 1998

New class of glucocorticoids with an improved pharmacological profile

Jan. 15, 1998

Agents with affinity for 5-HT2 receptors under development at Janssen

Jan. 14, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Novel ET antagonists claimed by BASF

Jan. 14, 1998

Serotonergic agents prepared at Merck KGaA as potential antidepressants/anxiolytics

Jan. 14, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

PDE IV/TNF production inhibitors claimed by Schering AG for MS

Jan. 14, 1998

Pharmacia & Upjohn prepares MMP inhibitors

Jan. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...